Translational Sciences Corporation (TSC) announced that it has received FDA 510(k) clearance for commercialization of its OncoTrac™ medical imaging software. OncoTrac™ is designed for efficient quantitative assessment of treatment response of metastatic tumors including breast, lung, colorectal, prostate, and lymphoma…

Read more:
Translational Sciences Corporation Receives FDA 510(k) Clearance For Commercialization Of OncoTrac™ In The United States